StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) shareholders

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Ownership

Institutional holdings as of Sep 30, 2025, from 13F filings

Held by institutions
0.1%
0M of 31M shares
Institutional holders
1
0 new, 0 sold out
Net institutional buying
0M
In Q3 2025
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
DeSantis Damon
Joint filing with Cdds 2.0, LLC (41.00%)
12,920,55841.30%13D (active)Apr 15, 2026

Top institutional holders

13F holdings as of Sep 30, 2025

HolderShares% of INBPValueChange% of portfolio
Moloney Securities Asset Management, LLC20,0000.06%$5.80K–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q3 202510M0.1%0 / 00 / 00M0M
Q2 202510M0.1%0 / 00 / 00M0M
Q1 202510M0.1%0 / 00 / 00M0M
Q4 202410M0.1%0 / 00 / 00M0M
Q3 202410M0.1%0 / 00 / 00M0M
Q2 202410M0.1%0 / 00 / 00M0M
Q1 202410M0.1%0 / 00 / 00M0M
Q4 202310M0.1%0 / 00 / 00M0M
Q3 202310M0.1%0 / 00 / 00M0M
Q2 202310M0.1%0 / 00 / 00M0M
Q1 202310M0.1%0 / 00 / 00M0M
Q4 202210M0.1%0 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Christina KayCo-Chief Executive Officer, Director, 10% owner4,883,97915.72%Dec 10, 2025
Sheppard RivaCo-Chief Executive Officer, 10% owner4,899,67915.78%Dec 10, 2025
Dina MasiChief Financial Officer347,2001.12%Dec 10, 2025
Robert CanarickDirector234,2330.75%Jun 25, 2026
William H. MilmoeDirector2,512,7518.09%Jun 25, 2026
Damon DeSantisDirector, 10% owner10,497,64133.80%Jun 25, 2026
Eric J. FriedmanDirector0–Jun 25, 2026
Carl Desantis10% owner2,352,8267.58%Apr 17, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Damon DeSantis
Director, 10% owner
Apr 15, 2026Gift+8,966,547––10,497,641
Damon DeSantis
Director, 10% owner
Apr 15, 2026Gift+2,235,417––12,733,058
Carl Desantis
10% owner
Apr 15, 2026Gift−8,966,547––2,235,417
Carl Desantis
10% owner
Apr 15, 2026Gift−2,235,417––0
William H. Milmoe
Director
Apr 15, 2026Gift−2,235,417––138,667
William H. Milmoe
Director
Apr 15, 2026Gift−8,966,547––2,374,084
William H. Milmoe
Director
Apr 15, 2026Gift−2,235,417––138,667
William H. Milmoe
Director
Apr 15, 2026Gift−8,966,547––2,374,084
Carl Desantis
10% owner
Mar 24, 2026Gift−1,356,293––11,374,065
Carl Desantis
10% owner
Mar 24, 2026Gift−7,392––11,366,673
William H. Milmoe
Director, 10% owner
Mar 24, 2026Gift−1,356,293––11,512,732
William H. Milmoe
Director, 10% owner
Mar 24, 2026Gift−7,392––11,505,340
Damon DeSantis
Director
Mar 24, 2026Gift+7,392––1,363,685
Damon DeSantis
Director
Mar 24, 2026Gift+1,356,293––1,356,293
William H. Milmoe
Director, 10% owner
May 30, 2025Award+50,000$0.09$4.50K138,667
Robert Canarick
Director
May 21, 2025Award+175,000$0.09$15.75K234,233
Dina Masi
Chief Financial Officer
May 21, 2025Award+135,000$0.09$12.15K347,200
Sheppard Riva
Co-Chief Executive Officer, Director, 10% owner
May 21, 2025Award+144,445$0.09$13.00K1,473,467
Christina Kay
Co-Chief Executive Officer, Director, 10% owner
May 21, 2025Award+144,445$0.09$13.00K1,473,467
Dina Masi
Chief Financial Officer
Nov 25, 2024Award+65,000$0.09$5.85K212,200
Sheppard Riva
Co-Chief Executive Officer, Director, 10% owner
Nov 25, 2024Award+55,555$0.09$5.00K1,329,022
Christina Kay
Co-Chief Executive Officer, Director, 10% owner
Nov 25, 2024Award+55,555$0.09$5.00K1,329,022
Dina Masi
Chief Financial Officer
Sep 20, 2023Award+50,000$0.09$4.50K147,200
Sheppard Riva
Co-Chief Executive Officer, Director, 10% owner
Sep 20, 2023Award+50,000$0.09$4.50K1,273,467
Christina Kay
Co-Chief Executive Officer, Director, 10% owner
Sep 20, 2023Award+50,000$0.09$4.50K1,273,467
Christina Kay
Co-Chief Executive Officer, Director
May 30, 2023Gift+50,000$0.34$17.00K1,811,800
Sheppard Riva
Co-Chief Executive Officer, Director
May 30, 2023Gift+50,000$0.34$17.00K1,811,800
Sheppard Riva
Co-Chief Executive Officer, Director, 10% owner
May 25, 2023Award+3,410,512$0.40$1.36M3,426,212
Christina Kay
Co-Chief Executive Officer, Director, 10% owner
May 25, 2023Award+3,410,512$0.40$1.36M3,410,512
E. Gerald Kay
Executive Chairman & President, Director, 10% owner
Mar 20, 2023Inheritance−853,022––0
E. Gerald Kay
Executive Chairman & President, Director, 10% owner
Mar 20, 2023Inheritance−4,299,533––0
E. Gerald Kay
Executive Chairman & President, Director, 10% owner
May 6, 2022Option exercise+100,000$0.23$23.00K5,345,889
E. Gerald Kay
Executive Chairman & President, Director, 10% owner
May 6, 2022Award+100,000$0.23$23.00K5,345,889
E. Gerald Kay
Chief Executive Officer, Director, 10% owner
Dec 19, 2018Award+100,000$0.10$10.00K5,262,556
Sheppard Riva
Executive Vice President, Director
Dec 19, 2018Award+50,000$0.14$7.00K1,423,467
Sheppard Riva
Executive Vice President, Director
Dec 19, 2018Award+50,000$0.14$7.00K1,173,467
Christina Kay
Executive Vice President, Director
Dec 19, 2018Award+50,000$0.14$7.00K1,423,467
Christina Kay
Executive Vice President, Director
Dec 19, 2018Award+50,000$0.14$7.00K1,173,467
CD Financial, LLC
10% owner
Jul 31, 2018Other+8,230,769$0.65$5.35M10,524,173
William H. Milmoe
Director, 10% owner
Jul 31, 2018Other+8,230,769$0.65$5.35M188,667
Carl Desantis
Director, 10% owner
Jul 31, 2018Other+8,230,769$0.65$5.35M117,409
E. Gerald Kay
CEO AND PRESIDENT, Director, 10% owner
Jun 27, 2012Sale−250,000$0.09$22.50K5,270,444
CD Financial, LLC
10% owner
May 21, 2012Other+50,000––4,456,293
William H. Milmoe
Director, 10% owner
May 21, 2012Other+50,000––4,582,960
Carl Desantis
Director, 10% owner
May 21, 2012Other+50,000––6,771,011
CD Financial, LLC
10% owner
Feb 21, 2012Other+50,000––4,406,293
William H. Milmoe
Director, 10% owner
Feb 21, 2012Other+50,000––4,532,960
Carl Desantis
Director, 10% owner
Feb 21, 2012Other+50,000––6,721,011
CD Financial, LLC
10% owner
Nov 21, 2011Other+50,000––4,356,293
William H. Milmoe
Director, 10% owner
Nov 21, 2011Other+50,000––4,482,960
Carl Desantis
Director, 10% owner
Nov 21, 2011Other+50,000––6,671,011
CD Financial, LLC
10% owner
Aug 21, 2011Other+50,000––4,306,293
William H. Milmoe
Director, 10% owner
Aug 21, 2011Other+50,000––4,432,960
Carl Desantis
Director, 10% owner
Aug 21, 2011Other+50,000––6,621,011
CD Financial, LLC
10% owner
May 21, 2011Other+50,000––4,256,293
William H. Milmoe
Director, 10% owner
May 21, 2011Other+50,000––4,382,960
Carl Desantis
Director, 10% owner
May 21, 2011Other+50,000––6,571,011
CD Financial, LLC
10% owner
Feb 21, 2011Other+50,000––4,206,293
William H. Milmoe
Director, 10% owner
Feb 21, 2011Other+50,000––4,332,960
Carl Desantis
Director, 10% owner
Feb 21, 2011Other+50,000––6,521,011

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
0.0%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Integrated BioPharma's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?